Eagle Capital sold out its entire stake in Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) (TLV:TEVA). It owned 22,400 shares of the pharmaceuticals company at the beginning of the December quarter. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock opened at $50.49 in last session, and closed at $49.30, while the day range of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock is $49.24 – $50.70. The stock showed a positive weekly performance of -1.18%.
With the commencement of 2014, several companies have been providing updates on the regulatory front and their future developmental plans. Earlier this week, Forest Laboratories, Inc. (NYSE:FRX) and partner Adamas Pharmaceuticals Inc. provided an update on the regulatory front. Forest Labs and Adamas said that they have filed a New Drug Application (NDA). Forest Laboratories, Inc. (NYSE:FRX) stock opened at $95.58 in last session, and closed at $94.68 by losing -0.53%. The 52 week range of $35.22 – $100.88. Company’s market capitalization is $25.51 billion.
Dynavax Technologies Corporation (NASDAQ:DVAX) recently reported a $5.4 million milestone payment from its collaborator, AstraZeneca. Dynavax Technologies Corporation (NASDAQ:DVAX) stock decreased -2.07% and finished the last session at $1.89. The EPS of the stock remained -0.41. Company’s market capitalization is $345.91 million.
Endo International plc (NASDAQ:ENDP), formerly Endo Health Solutions Inc., announced on 5 march that it has completed the acquisition of Paladin Labs Inc. in a stock and cash transaction currently valued at approximately $2.7 billion. Endo Health Solutions Inc. (NASDAQ:ENDP) stock opened the session at $73.99, and closed the session at $73.76. The 52 week range of the Endo Health Solutions Inc. (NASDAQ:ENDP) stock remained $29.94 – $82.16 and the day range was $71.52 – $74.54.